Advancing Health Equity in Belgium: Challenges, Choices & Change Across the Medicine Lifecycle
On this day, Pharma.be and Healixia are bringing together leading experts, policymakers, industry representatives and patient voices to explore how equity can be embedded at every stage of the medicine lifecycle.
-
-
-
Welcome & Introduction
-
-
-
-
Equity as the foundation of a future-proof healthcare system - Prof. dr. Sara Willems, Ghent University, Department of Public Health and Primary Care
-
-
-
-
Health Equity along the Medicine Life Cycle
More information
- Missed, Misread, Misdiagnosed: The Gender Gap and Women’s Health at the Intersection of Science and Society (Prof. Dr. Bharati Shivalkar, Women’s Heart Health Advocate - Consultant Cardiologist Delta (CHIREC) Hospital and RIVA Medical - Board member Heart Health India Foundation - Past Pharma Executive.)
- IHI-READI project, equity in clinical trials (Nicholas Brooke, Executive Director, the Synergist)
- End-to-end Health Equity: A Gilead Sciences perspective (Dr. Reon van Dyk, Associate Director Medical Affairs Virology, Gilead)
- From Diagnosis to Real Life: The Missing Pieces of Health Equity in the Cancer Journey (Atefeh Sadeghi, Founder of women cancer Europe (WCE), a patient-led platform turning lived experience into systemic change)
- Information for Patients: Vulnerable Groups and the Need to Adapt Communication Style (Laura De Meester, Project Coordinator FarmaInfo – Patient information on medicines for human use, FAMHP)
-
-
-
-
Networking Break
-
-
-
-
Bringing it all together
More information
45’ debate and Q&A with audience with Katrina Grosfils (FAMHP), Prof. dr. Bharati Shivalkar (Women’s Heart Health Advocate), Nicholas Brooke (Executive Director, The Synergist), Dr. Reon van Dyk (Associate Director Medical Affairs Virology, Gilead), Atefeh Sadeghi (Founder Women Cancer Europe).
-
-
-
-
Closing Remarks
-
-
-
-
Networking Drink
-